Ftse Mib
34.743,33
0,73%
DAX
18.635,54
0,82%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
69.082,01
1,97%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Bristol Myers Squibb Co (BMY) Bristol Myers Squibb Co (BMY) Notizie

Bristol Myers Squibb Co

BMY
41,10
0,01 (0,02%)
Pre Mercato
Ultimo aggiornamento: 11:49:55
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/6/202414:00BWKRAZATI (adagrasib) Demonstrated Statistically Significant..
30/5/202417:51BWU.S. Food and Drug Administration Approves Bristol Myers..
29/5/202412:59BWBristol Myers Squibb Receives European Commission Approval..
23/5/202423:05BWBristol Myers Squibb to Present Data at ASCO & EHA from More..
23/5/202413:40IHMARKETNEWSOpenAI and News Corp Seal Partnership, DuPont de Nemours..
23/5/202412:59BWBristol Myers Squibb to Present Data at the 2024 American..
22/5/202412:59BWBristol Myers Squibb Announces 10-Year Strategy to Reach..
22/5/202409:30PRNUSNeoPhore closes oversubscribed Series B extension round with..
21/5/202414:45BWBristol Myers Squibb, Taye Diggs and Schizophrenia Community..
21/5/202412:59BWBristol Myers Squibb Announces Updated Action Date by the..
16/5/202416:26BWNew Four-Year Sotyktu (deucravacitinib) Data Demonstrate..
16/5/202402:57BWBristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved..
13/5/202413:16IHMARKETNEWSArm Sets 2025 Target for AI Chip Development, Amazon and..
10/5/202422:30BWBristol Myers Squibb Provides Update on Phase 3 CheckMate..
07/5/202412:59BWBristol Myers Squibb to Participate in Upcoming Investor..
06/5/202412:59BWEuropean Medicines Agency Validates Bristol Myers Squibb’s..
01/5/202414:00GLOBEEditas Medicine and Bristol Myers Squibb Extend Alpha-Beta T..
29/4/202412:00PRNUSRepertoire® Immune Medicines and Bristol Myers Squibb..
26/4/202412:59BWCHMP Adopts Positive Opinion Recommending Approval of..
25/4/202413:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
25/4/202412:59BWBristol Myers Squibb Reports First Quarter Financial Results..
23/4/202413:25IHMARKETNEWSApple Loses Market Share in China, GM Surges in Pre-Market..
22/4/202412:59BWBristol Myers Squibb and Cellares Announce a $380M Worldwide..
08/4/202417:30BWKRAZATI (adagrasib) in Combination with Cetuximab..
06/4/202419:15BWBristol Myers Squibb Presents New Interim Long-Term Efficacy..
05/4/202415:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
03/4/202402:08BWEuropean Commission Expands Approval of Bristol Myers..
02/4/202412:59BWBristol Myers Squibb Releases 2023 Environmental, Social and..
28/3/202421:05BWBristol Myers Squibb Announces Pivotal KRYSTAL-12..
28/3/202421:01BWBristol Myers Squibb Provides Update on the First Phase 3..
28/3/202412:30GLOBEPerspective Therapeutics Provides Recent Business Highlights..
26/3/202419:25BWA Bristol Myers Squibb Expande as Iniciativas de Doações..
26/3/202411:59BWBristol Myers Squibb Expands Health Equity Grant Initiatives..
25/3/202413:00BWBristol Myers Squibb to Present Data at the American College..
20/3/202421:45BWBristol Myers Squibb’s Abecma (idecabtagene vicleucel)..
20/3/202411:59BWBristol Myers Squibb Announces CheckMate -9DW Trial..
19/3/202411:59BWBristol Myers Squibb and Ted Danson Empower Those with..
18/3/202413:44BWBristol Myers Squibb Completes Acquisition of Karuna..
15/3/202423:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
15/3/202402:35BWU.S. FDA Approves Bristol Myers Squibb’s Breyanzi® as the..
11/3/202421:16BWBristol Myers Squibb to Report Results for First Quarter..
07/3/202420:23BWU.S. Food and Drug Administration Approves Opdivo®..
06/3/202422:17BWBristol Myers Squibb to Participate in Upcoming Investor..
04/3/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/3/202422:16BWBristol Myers Squibb Announces Dividend
29/2/202412:59BWBristol Myers Squibb Announces New Data from the Long-Term..
26/2/202422:16BWBristol Myers Squibb to Participate in the TD Cowen 44th..
26/2/202414:35BWBristol Myers Squibb Completes Acquisition of RayzeBio,..
24/2/202400:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
Apertura: Min: Max:
Chiusura: 41,09

La tua Cronologia

NYSE
BMY
Bristol Myers Squibb
BIT
UC08VD
Unicredit Bank
BMF
DIFM24V24
DIFM24V24 - 06/2024
USOTC
MZZMF
Matador Mining (QB)
BIT
PHIA
Koninklijke Philips NV
BIT
S29099
Societe Generale Effekten
BIT
P15YS3
BNP Paribas Issuance
EU
I3AMZ
LS 3AMZ INAV
BIT
I06830
Intesa Sanpaolo
BIT
O8JPV1
Morgan Stanley BV
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network